1
Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma
Condition(s):Relapsed and Refractory Multiple MyelomaLast Updated:December 17, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Relapsed and Refractory Multiple MyelomaLast Updated:December 17, 2020Completed
Condition(s):MyelofibrosisLast Updated:February 9, 2022Completed
Condition(s):Refractory Multiple Myeloma; Relapse Multiple MyelomaLast Updated:August 19, 2020Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.